Literature DB >> 11157678

Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development.

A Dube1, S Thai, J Gaspar, S Rudders, T A Libermann, L Iruela-Arispe, P Oettgen.   

Abstract

Vascular development requires the tightly coordinated expression of several growth factors and their receptors. Among these are the Tie1 and Tie2 receptors, which are almost exclusively endothelial cell-specific. The critical transcriptional regulators of vascular-specific gene expression remain largely unknown. The Ets factors are a family of evolutionarily conserved transcription factors that regulate genes involved in cellular growth and differentiation. We have recently shown that the Ets factor NERF is a strong transactivator of the Tie1 and Tie2 genes. To extend these studies, we have begun to identify the Ets factors that are expressed in developing blood vessels of the chicken chorioallantoic membrane (CAM), a highly vascular embryonic network. RNA was extracted from microdissected CAM blood vessels, and reverse transcriptase-polymerase chain reaction was performed using oligonucleotides encoding conserved amino acids within the Ets domain. One of the polymerase chain reaction fragments was subcloned and identified as the chicken homologue of the Ets factor ELF-1, cELF-1. ELF-1 is most closely related to the Ets factor NERF. In situ hybridization and immunohistochemistry demonstrate that cELF-1 is enriched in developing chicken blood vessels. cELF-1 is also a strong transactivator of the Tie1 and Tie2 genes and can bind to conserved Ets sites within the promoters of these genes. A complex of similar size forms when gel shifts are performed with cellular extracts derived from the CAM blood vessels, which is recognized by an antibody against cELF-1. In summary, ELF-1 belongs to a subset of Ets factors that regulate vascular-specific gene expression during blood vessel development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157678     DOI: 10.1161/01.res.88.2.237

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  21 in total

1.  The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

Authors:  Berthold Göttgens; Cyril Broccardo; Maria-Jose Sanchez; Sophie Deveaux; George Murphy; Joachim R Göthert; Ekaterini Kotsopoulou; Sarah Kinston; Liz Delaney; Sandie Piltz; Linda M Barton; Kathy Knezevic; Wendy N Erber; C Glenn Begley; Jonathan Frampton; Anthony R Green
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

2.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

3.  RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG.

Authors:  Lei Yuan; Anastasia Sacharidou; Amber N Stratman; Alexandra Le Bras; Peter J Zwiers; Katherine Spokes; Manoj Bhasin; Shou-Ching Shih; Janice A Nagy; Grietje Molema; William C Aird; George E Davis; Peter Oettgen
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

Review 4.  Cellular Based Strategies for Microvascular Engineering.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Denis Pasic; Anoosha Forghani; Shane Lince; Daniel J Hayes; Ibrahim T Ozbolat; Dino J Ravnic
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

5.  The transcription factor E74-like factor controls quiescence of endothelial cells and their resistance to myeloablative treatments in bone marrow.

Authors:  Mariela Sivina; Takeshi Yamada; Chun Shik Park; Monica Puppi; Suleyman Coskun; Karen Hirschi; H Daniel Lacorazza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-24       Impact factor: 8.311

6.  Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle.

Authors:  Ju Liu; Lei Yuan; Grietje Molema; Erzsébet Regan; Lauren Janes; David Beeler; Katherine C Spokes; Yoshiaki Okada; Takashi Minami; Peter Oettgen; William C Aird
Journal:  Blood       Date:  2010-10-27       Impact factor: 22.113

7.  The role of ets factors in tumor angiogenesis.

Authors:  Peter Oettgen
Journal:  J Oncol       Date:  2010-05-04       Impact factor: 4.375

8.  Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation.

Authors:  Fernando J Calero-Nieto; Andrew D Wood; Nicola K Wilson; Sarah Kinston; Josette-Renée Landry; Berthold Göttgens
Journal:  Nucleic Acids Res       Date:  2010-06-04       Impact factor: 16.971

9.  Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene.

Authors:  Lei Yuan; Vesna Nikolova-Krstevski; Yumei Zhan; Maiko Kondo; Manoj Bhasin; Laya Varghese; Kiichiro Yano; Chris V Carman; William C Aird; Peter Oettgen
Journal:  Circ Res       Date:  2009-04-09       Impact factor: 17.367

Review 10.  ETS transcription factors in embryonic vascular development.

Authors:  Michael P Craig; Saulius Sumanas
Journal:  Angiogenesis       Date:  2016-04-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.